InsiderTrades.com logo
Breaking News: Tesla headed to $500…
From WealthPress   |   Ad
That headline hit late last night…and the rally has begun Which is why we want to urge you to go ahead and download Lance’s e-Book now outlining his bullish case for Tesla.
So to claim your free digital copy today, simply follow this link and enter your email address. 

CGON Insider Trading

Insider Ownership Percentage: N/A
Insider Buying (Last 12 Months): $12,662,968.00
Insider Selling (Last 12 Months): $23,000,088.80

CG Oncology Insider Trading History Chart

This chart shows the insider buying and selling history at CG Oncology by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

CG Oncology Share Price & Price History

Current Price: $32.34
Price Change: ▲ Price Increase of +0.1 (0.31%)
As of 11/21/2024 01:00 AM ET

This chart shows the closing price history over time for CGON up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
917 Trades… Zero Losses?
From Insiders Exposed   |   Ad
As you likely know, the “Trump bump” launched stocks to record highs after he secured his second reelection bid. Now, Trump and his team are coming to gut government regulation – and it’s going to create some incredible market opportunities. But while the masses chase large-cap tech and so-called AI stocks, a small circle of traders are using a strange but tactical method to find a pool of “hidden Trump trades.”
Go here to see how you can start accessing these opportunities today

CG Oncology Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
8/29/2024Hong Fang SongDirectorSell650,455$35.36$23,000,088.80586,982View SEC Filing Icon  
1/29/2024Corleen M RocheCFOBuy2,000$19.00$38,000.002,000View SEC Filing Icon  
1/29/2024Decheng Capital Global Life ScMajor ShareholderBuy400,000$19.00$7,600,000.00400,000View SEC Filing Icon  
1/29/2024Hong Fang SongDirectorBuy263,157$19.00$4,999,983.00613,928View SEC Filing Icon  
1/29/2024Vijay KasturiInsiderBuy1,315$19.00$24,985.001,315View SEC Filing Icon  
See Full Table
When it comes to NVDA… “acceleration cycles” are the key
From DTI   |   Ad
Expert options trader Graham Lindman has been working on a new way to tap into Nvidia’s options… By simply isolating outsized “acceleration cycles” within Nvidia stock (most investors don’t even know it exists)... And thanks to many months and late nights working out the kinks of the systems… They have finally found a way to target these cycles on Nvidia over and over again.
Use this link to see Nvidia Unchained right away!

SEC Filings (Institutional Ownership Changes) for CG Oncology (NASDAQ:CGON)

26.56% of CG Oncology stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at CGON by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

CG Oncology Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
11/18/2024Neo Ivy Capital Management29,678$1.12M0.4%N/A0.044%Search for SEC Filing on Google Icon
11/16/2024Geode Capital Management LLC1,078,527$40.70M0.0%+96.2%1.608%Search for SEC Filing on Google Icon
11/15/2024M&T Bank Corp16,758$0.63M0.0%+55.7%0.025%Search for SEC Filing on Google Icon
11/15/2024Barclays PLC90,520$3.42M0.0%+331.1%0.134%Search for SEC Filing on Google Icon
11/15/2024Jane Street Group LLC195,951$7.39M0.0%+240.5%0.292%Search for SEC Filing on Google Icon
11/15/2024Wellington Management Group LLP510,219$19.25M0.0%+153.4%0.761%Search for SEC Filing on Google Icon
11/15/2024State Street Corp1,700,653$64.17M0.0%+73.0%2.535%Search for SEC Filing on Google Icon
11/15/2024Point72 Asset Management L.P.746,063$28.15M0.1%+575.7%1.112%Search for SEC Filing on Google Icon
11/15/2024Polar Asset Management Partners Inc.25,800$0.97M0.0%N/A0.038%Search for SEC Filing on Google Icon
11/15/2024Janus Henderson Group PLC1,526,534$57.60M0.0%+7.0%2.276%Search for SEC Filing on Google Icon
11/15/2024HighVista Strategies LLC15,734$0.59M0.2%N/A0.023%Search for SEC Filing on Google Icon
11/15/2024ArrowMark Colorado Holdings LLC230,390$8.69M0.1%+17.4%0.343%Search for SEC Filing on Google Icon
11/14/2024Braidwell LP3,170,875$119.64M3.4%-4.2%4.727%Search for SEC Filing on Google Icon
11/14/2024UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC21,122$0.80M0.0%-10.6%0.031%Search for SEC Filing on Google Icon
11/14/2024Ally Bridge Group NY LLC263,266$9.93M5.3%+50.5%0.392%Search for SEC Filing on Google Icon
11/14/2024Zurcher Kantonalbank Zurich Cantonalbank 6,399$0.24M0.0%N/A0.010%Search for SEC Filing on Google Icon
11/14/2024Yu Fan163,456$6.17M19.0%-89.6%0.244%Search for SEC Filing on Google Icon
11/14/2024ABG WTT Global Life Science Capital Partners GP Ltd495,526$18.70M92.9%-45.9%0.739%Search for SEC Filing on Google Icon
11/14/2024MetLife Investment Management LLC27,132$1.02M0.0%+103.2%0.040%Search for SEC Filing on Google Icon
11/13/2024BNP Paribas Financial Markets26,660$1.01M0.0%+876.9%0.040%Search for SEC Filing on Google Icon
11/13/2024FMR LLC145,606$5.49M0.0%+83,581.6%0.217%Search for SEC Filing on Google Icon
11/13/2024The Manufacturers Life Insurance Company 73,149$2.76M0.0%+21.3%0.109%Search for SEC Filing on Google Icon
11/12/2024Charles Schwab Investment Management Inc.379,664$14.33M0.0%+114.0%0.566%Search for SEC Filing on Google Icon
11/12/2024Massachusetts Financial Services Co. MA279,945$10.56M0.0%+4.9%0.417%Search for SEC Filing on Google Icon
11/4/2024Los Angeles Capital Management LLC22,052$0.83M0.0%N/A0.033%Search for SEC Filing on Google Icon
11/4/2024TimesSquare Capital Management LLC437,069$16.49M0.2%+27.4%0.652%Search for SEC Filing on Google Icon
10/30/2024Amalgamated Bank1,621$61K0.0%+107.6%0.002%Search for SEC Filing on Google Icon
10/3/2024SG Americas Securities LLC17,595$0.66M0.0%N/A0.026%Search for SEC Filing on Google Icon
9/16/2024Point72 Asia Singapore Pte. Ltd.1,209$38K0.0%-75.5%0.002%Search for SEC Filing on Google Icon
8/19/2024Point72 Asset Management L.P.110,410$3.49M0.0%-40.7%0.166%Search for SEC Filing on Google Icon
8/16/2024Perceptive Advisors LLC733,695$23.16M0.6%-43.7%1.101%Search for SEC Filing on Google Icon
8/16/2024Driehaus Capital Management LLC106,951$3.38M0.0%-0.9%0.160%Search for SEC Filing on Google Icon
8/15/2024Scientech Research LLC8,803$0.28M0.1%-27.8%0.013%Search for SEC Filing on Google Icon
8/15/2024The Manufacturers Life Insurance Company60,301$1.90M0.0%-5.4%0.090%Search for SEC Filing on Google Icon
8/15/2024Deerfield Management Company L.P. Series C433,540$13.69M0.2%+811.9%0.651%Search for SEC Filing on Google Icon
8/15/2024Point72 Asia Singapore Pte. Ltd.1,209$38K0.0%-75.5%0.002%Search for SEC Filing on Google Icon
8/14/2024Marshall Wace LLP75,982$2.40M0.0%N/A0.114%Search for SEC Filing on Google Icon
8/14/2024Yu Fan1,578,344$49.83M65.1%N/A2.368%Search for SEC Filing on Google Icon
8/14/2024Ally Bridge Group NY LLC174,876$5.52M3.3%-45.4%0.262%Search for SEC Filing on Google Icon
8/14/2024Profund Advisors LLC9,513$0.30M0.0%N/A0.014%Search for SEC Filing on Google Icon
8/13/2024Ensign Peak Advisors Inc60,565$1.91M0.0%N/A0.091%Search for SEC Filing on Google Icon
8/9/2024Renaissance Technologies LLC43,200$1.36M0.0%+204.2%0.065%Search for SEC Filing on Google Icon
8/9/2024Massachusetts Financial Services Co. MA266,787$8.42M0.0%+2.7%0.400%Search for SEC Filing on Google Icon
8/3/2024TD Asset Management Inc93,084$2.94M0.0%N/A0.140%Search for SEC Filing on Google Icon
8/1/2024Rhumbline Advisers34,229$1.08M0.0%+13.0%0.051%Search for SEC Filing on Google Icon
7/26/2024Bank of New York Mellon Corp89,344$2.82M0.0%+38.4%0.134%Search for SEC Filing on Google Icon
5/17/2024RA Capital Management L.P.1,397,433$61.35M0.8%N/A2.097%Search for SEC Filing on Google Icon
5/16/2024California State Teachers Retirement System2,341$0.10M0.0%N/A0.004%Search for SEC Filing on Google Icon
5/16/2024Janus Henderson Group PLC1,521,432$66.76M0.0%N/A2.283%Search for SEC Filing on Google Icon
5/16/2024BVF Inc. IL1,884,191$82.72M2.3%N/A2.827%Search for SEC Filing on Google Icon
5/16/2024Blackstone Inc.25,000$1.10M0.0%N/A0.038%Search for SEC Filing on Google Icon
5/15/2024Price T Rowe Associates Inc. MD992,118$43.56M0.0%N/A1.489%Search for SEC Filing on Google Icon
5/15/2024Avoro Capital Advisors LLC700,000$30.73M0.4%N/A1.050%Search for SEC Filing on Google Icon
5/14/2024StemPoint Capital LP40,723$1.79M0.5%N/A0.061%Search for SEC Filing on Google Icon
5/14/2024Decheng Capital LLC5,458,810$239.64M32.1%N/A8.191%Search for SEC Filing on Google Icon
5/14/2024American International Group Inc.306,226$13.44M0.0%N/A0.460%Search for SEC Filing on Google Icon
5/13/2024Ameritas Investment Partners Inc.2,320$0.10M0.0%N/A0.003%Search for SEC Filing on Google Icon
5/10/2024Vanguard Group Inc.2,225,018$97.68M0.0%N/A3.339%Search for SEC Filing on Google Icon
5/7/2024TimesSquare Capital Management LLC224,073$9.84M0.1%N/A0.336%Search for SEC Filing on Google Icon
5/1/2024Capstone Investment Advisors LLC18,354$0.81M0.0%N/A0.028%Search for SEC Filing on Google Icon
5/1/2024BNP Paribas Financial Markets11,198$0.49M0.0%N/A0.017%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
CG Oncology logo
CG Oncology, Inc., an oncolytic immunotherapy company, focuses on developing and commercializing backbone bladder-sparing therapeutics for patients with bladder cancer. The company develops BOND-003 for the treatment of high-risk bacillus calmette guerin (BCG)-unresponsive non-muscle invasive bladder cancer (NMIBC) patients; CORE-001 to treat cretostimogene in combination with pembrolizumab in high-risk BCG-unresponsive NMIBC patients; and CORE-002 for the treatment of cretostimogene in combination with the checkpoint inhibitor nivolumab in muscle invasive bladder cancer patients. It also develops PIVOT-006, a cretostimogene monotherapy for intermediate-risk NMIBC following transurethral resection of the bladder tumor; and CORE-008 for treating patients with high-risk NMIBC, including BCG-exposed and BCG-naïve NMIBC patients. CG Oncology, Inc. was formerly known as Cold Genesys, Inc. and changed its name to CG Oncology, Inc. in June 2020. The company was founded in 2010 and is based in Irvine, California.
Read More on CG Oncology

Today's Range

Now: $32.34
Low: $31.28
High: $33.16

50 Day Range

MA: $36.45
Low: $32.24
High: $39.94

52 Week Range

Now: $32.34
Low: $25.77
High: $50.23

Volume

588,670 shs

Average Volume

646,967 shs

Market Capitalization

$2.19 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Who are the company insiders with the largest holdings of CG Oncology?

CG Oncology's top insider investors include:
  1. Hong Fang Song (Director)
  2. Decheng Capital Global Life Sc (Major Shareholder)
  3. Corleen M Roche (CFO)
  4. Vijay Kasturi (Insider)
Learn More about top insider investors at CG Oncology.

Who are the major institutional investors of CG Oncology?

CG Oncology's top institutional shareholders include:
  1. Braidwell LP — 4.73%
  2. State Street Corp — 2.54%
  3. Janus Henderson Group PLC — 2.28%
  4. Geode Capital Management LLC — 1.61%
  5. Point72 Asset Management L.P. — 1.11%
  6. Wellington Management Group LLP — 0.76%
Learn More about top institutional investors of CG Oncology stock.

Which institutional investors are selling CG Oncology stock?

During the last quarter, CGON stock was sold by these institutional investors:
  1. Yu Fan
  2. ABG WTT Global Life Science Capital Partners GP Ltd
  3. Braidwell LP
  4. UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC

Which institutional investors are buying CG Oncology stock?

Within the last quarter, CGON stock was acquired by institutional investors including:
  1. State Street Corp
  2. Point72 Asset Management L.P.
  3. Geode Capital Management LLC
  4. Wellington Management Group LLP
  5. Charles Schwab Investment Management Inc.
  6. FMR LLC
  7. Jane Street Group LLC
  8. Janus Henderson Group PLC
In the last year, these company insiders have bought CG Oncology stock:
  1. Hong Fang Song (Director)
  2. Decheng Capital Global Life Sc (Major Shareholder)
  3. Corleen M Roche (CFO)
  4. Vijay Kasturi (Insider)
Learn More investors buying CG Oncology stock.
Breaking News: Tesla headed to $500…
From WealthPress   |   Ad
That headline hit late last night…and the rally has begun Which is why we want to urge you to go ahead and download Lance’s e-Book now outlining his bullish case for Tesla.
So to claim your free digital copy today, simply follow this link and enter your email address.